GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Global Health Ltd (NSE:MEDANTA) » Definitions » Beneish M-Score

Global Health (NSE:MEDANTA) Beneish M-Score : -1.78 (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Global Health Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.78 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Global Health's Beneish M-Score or its related term are showing as below:

NSE:MEDANTA' s Beneish M-Score Range Over the Past 10 Years
Min: -2.32   Med: -2.05   Max: -1.78
Current: -1.78

During the past 5 years, the highest Beneish M-Score of Global Health was -1.78. The lowest was -2.32. And the median was -2.05.


Global Health Beneish M-Score Historical Data

The historical data trend for Global Health's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Health Beneish M-Score Chart

Global Health Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Beneish M-Score
- - - -2.32 -1.78

Global Health Quarterly Data
Mar20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.32 -2.30 - - -1.78

Competitive Comparison of Global Health's Beneish M-Score

For the Medical Care Facilities subindustry, Global Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Global Health's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Global Health's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Global Health's Beneish M-Score falls into.



Global Health Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Global Health for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9174+0.528 * 1.0015+0.404 * 1.031+0.892 * 1.2086+0.115 * 0.9604
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.061+4.679 * 0.111071-0.327 * 0.7672
=-1.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ₹2,153 Mil.
Revenue was 8255.305 + 8326.017 + 8439.392 + 7730.396 = ₹32,751 Mil.
Gross Profit was 6317.89 + 6419.34 + 6503.597 + 5916.683 = ₹25,158 Mil.
Total Current Assets was ₹15,087 Mil.
Total Assets was ₹43,041 Mil.
Property, Plant and Equipment(Net PPE) was ₹26,179 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹1,727 Mil.
Selling, General, & Admin. Expense(SGA) was ₹4,270 Mil.
Total Current Liabilities was ₹6,177 Mil.
Long-Term Debt & Capital Lease Obligation was ₹6,300 Mil.
Net Income was 1272.482 + 1236.407 + 1251.609 + 1020.102 = ₹4,781 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₹0 Mil.
Cash Flow from Operations was 0 + 0 + 0 + 0 = ₹0 Mil.
Total Receivables was ₹1,942 Mil.
Revenue was 7190.485 + 6943.221 + 6790.555 + 6174.49 = ₹27,099 Mil.
Gross Profit was 5542.75 + 5363.64 + 5236.797 + 4702.714 = ₹20,846 Mil.
Total Current Assets was ₹15,795 Mil.
Total Assets was ₹41,160 Mil.
Property, Plant and Equipment(Net PPE) was ₹23,719 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹1,499 Mil.
Selling, General, & Admin. Expense(SGA) was ₹3,330 Mil.
Total Current Liabilities was ₹5,726 Mil.
Long-Term Debt & Capital Lease Obligation was ₹9,826 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2153.13 / 32751.11) / (1942.022 / 27098.751)
=0.065742 / 0.071665
=0.9174

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(20845.901 / 27098.751) / (25157.51 / 32751.11)
=0.769257 / 0.768142
=1.0015

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (15087.3 + 26179.03) / 43040.75) / (1 - (15794.886 + 23718.955) / 41159.64)
=0.041227 / 0.039986
=1.031

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=32751.11 / 27098.751
=1.2086

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1499.149 / (1499.149 + 23718.955)) / (1727.28 / (1727.28 + 26179.03))
=0.059447 / 0.061896
=0.9604

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(4270.28 / 32751.11) / (3330.11 / 27098.751)
=0.130386 / 0.122888
=1.061

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((6299.82 + 6177.33) / 43040.75) / ((9825.942 + 5725.531) / 41159.64)
=0.289892 / 0.377833
=0.7672

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(4780.6 - 0 - 0) / 43040.75
=0.111071

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Global Health has a M-score of -1.78 suggests that the company is unlikely to be a manipulator.


Global Health Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Global Health's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Health (NSE:MEDANTA) Business Description

Traded in Other Exchanges
Address
E - 18, Medanta - The Medicity, Defence Colony, New Delhi, IND, 110024
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.

Global Health (NSE:MEDANTA) Headlines

No Headlines